Apelin promotes diabetic nephropathy by inducing podocyte dysfunction via inhibiting proteasome activities. [electronic resource]
Producer: 20160411Description: 2273-85 p. digitalISSN:- 1582-4934
- Albumins -- metabolism
- Animals
- Apelin Receptors
- Basement Membrane -- drug effects
- Cell Membrane Permeability -- drug effects
- Creatinine -- metabolism
- Cyclic AMP -- pharmacology
- Diabetes Mellitus, Type 2 -- pathology
- Diabetic Nephropathies -- pathology
- Endoplasmic Reticulum Stress -- drug effects
- Female
- Glucose -- pharmacology
- Humans
- Intercellular Signaling Peptides and Proteins -- adverse effects
- Iridoid Glucosides
- Iridoids -- pharmacology
- Kidney -- drug effects
- Kidney Function Tests
- Male
- Mice, Inbred C57BL
- Middle Aged
- Podocytes -- drug effects
- Proteasome Endopeptidase Complex -- metabolism
- Proteasome Inhibitors -- pharmacology
- Receptors, G-Protein-Coupled -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.